In this study, we prospectively monitored CeD-associated antibody production, i.e., AGA, DGP and anti-tTG antibodies, in infants at genetic risk for CeD and correlated the antibody production profiles with systemic cytokine responses. This evidence concerns the gene TGM2 and cranioectodermal dysplasia.